Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600572 stock hub

SHA/600572 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/600572is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
11.2B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/600572
In the news

Latest news · SHA/600572

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E22.8
P25 23.5P50 41.3P75 83.2
ROE6.9
P25 -0.9P50 4.1P75 8.8
ROIC7.1
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/600572 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
245
Groups with data
11
Currency
CNY
Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
8,411
Employees Change
-4%
Employees Change Percent
-0.05
Enterprise value
CNY 10.6B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE000001H86
Last refreshed
2026-05-10
Market cap
CNY 11.2B
Price
CNY 4.41
Price currency
CNY
Rev Per Employee
795,877.8x
Sector
Healthcare
Sic
2833
Symbol
sha/600572
Website
https://www.conbapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
4.32%
EV Earnings
21.91x
EV/EBIT
18.1x
EV/EBITDA
11.52x
EV/FCF
12.05x
EV/Sales
1.58x
FCF yield
7.85%
P/B ratio
1.52x
P/E ratio
22.82x
P/S ratio
1.67x
PE Ratio10 Y
27.88x
PE Ratio3 Y
21.72x
PE Ratio5 Y
24.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
8.84%
EBITDA Margin
13.77%
FCF margin
13.13%
Gross margin
53.48%
Gross Profit
CNY 3.6B
Gross Profit Growth
8.56%
Gross Profit Growth Q
17.09%
Gross Profit Growth3 Y
-2.41%
Gross Profit Growth5 Y
-0.63%
Net Income
CNY 483.4M
Net Income Growth
-18.86%
Net Income Growth Q
4.78%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Net Income Growth3 Y
-3.57%
Net Income Growth5 Y
8.68%
Pretax Margin
10%
Profit Margin
7.22%
Profit Per Employee
CNY 57,474
Profitable Years
6
ROA
3.66
Roa5y
3.86
ROCE
7.63
ROE
6.93
Roe5y
12.89
ROIC
7.13
Roic5y
8.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

30
MetricValue
Cagr10y
-1.7%
Cagr15y
0.85%
Cagr1y
3.22%
Cagr20y
11.21%
Cagr3y
-12.34%
Cagr5y
3.4%
Div CAGR10
2.84%
Div CAGR3
-2.13%
Div CAGR5
0%
EPS Growth
-16.1
EPS Growth Q
21.88
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
-2.91
EPS Growth5 Y
8.36
FCF Growth
17.21%
FCF Growth Q
66.8%
FCF Growth3 Y
-0.55%
FCF Growth5 Y
6.38%
OCF Growth
1.09%
OCF Growth Q
46.59%
OCF Growth10 Y
0.54%
OCF Growth3 Y
-5.13%
OCF Growth5 Y
-2.12%
Revenue Growth
4.99x
Revenue Growth Q
13.1x
Revenue Growth Quarters
1x
Revenue Growth Years
0x
Revenue Growth3 Y
1.35x
Revenue Growth5 Y
2.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
CNY 0.66
Assets
CNY 10.2B
Cash
CNY 856.4M
Current Assets
CNY 4.9B
Current Liabilities
CNY 2.5B
Debt
CNY 150.4M
Debt EBITDA
CNY 0.16
Debt Equity
CNY 0.02
Debt FCF
CNY 0.17
Equity
CNY 7.4B
Interest Coverage
84.97
Liabilities
CNY 2.9B
Long Term Assets
CNY 5.3B
Long Term Liabilities
CNY 392.3M
Net Cash
CNY 706M
Net Cash By Market Cap
CNY 6.31
Net Cash Growth
42.84%
Net Debt EBITDA
CNY -0.77
Net Debt Equity
CNY -0.1
Net Debt FCF
CNY -0.8
Tangible Book Value
CNY 6.7B
Tangible Book Value Per Share
CNY 2.64
WACC
5.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.98
Inventory Turnover
2.72
Net Working Capital
CNY 1.7B
Quick ratio
1.15
Working Capital
CNY 2.4B
Working Capital Turnover
CNY 2.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
3.29%
Dividend Growth
-25%
Dividend Growth Years
0%
Dividend per share
CNY 0.15
Dividend Years
4
Dividend Yield
3.4%
Ex Div Date
2025-06-25
Last Dividend
CNY 0.15
Payout Frequency
Annual
Payout Ratio
79.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-15.76%
1Y total return
3.22%
200-day SMA
4.54
3Y total return
-32.64%
50-day SMA
4.44
50-day SMA vs 200-day SMA
50under200
5Y total return
18.2%
All Time High
13.19
All Time High Change
-66.56%
All Time High Date
2015-06-09
All Time Low
0.53
All Time Low Change
724.45%
All Time Low Date
2005-07-21
ATR
0.11
Beta
0.27
Beta1y
0.1
Beta2y
0.43
Ch YTD
-1.12
High
4.44
High52
5.17
High52 Date
2026-04-16
High52ch
-14.7%
Low
4.39
Low52
4.04
Low52 Date
2026-03-23
Low52ch
9.16%
Ma50ch
-0.63%
Price vs 200-day SMA
-2.78%
RSI
45.58
RSI Monthly
45.45
RSI Weekly
46.46
Sharpe ratio
0.09x
Sortino ratio
0.44
Total Return
6.69%
Tr YTD
-1.12
Tr15y
13.47%
Tr1w
-0.9%
Tr3m
-2.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 591.7M
Operating Income Growth
12.91
Operating Income Growth Q
32.41
Operating Income Growth3 Y
-10.35
Operating Income Growth5 Y
1.57
Operating margin
8.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
1,635,976,925%
Net Borrowing
-113,256,497
Shares Insiders
2.52%
Shares Institutions
5.34%
Shares Out
2,536,895,141
Shares Qo Q
4.51%
Shares Yo Y
-3.29%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

65
MetricValue
Adjusted FCF
CNY 878.6M
Average Volume
93,802,012.95x
Bv Per Share
2.86
CAPEX
CNY -134.2M
Ch10y
-31.17
Ch15y
-11.03
Ch1w
-0.9
Ch1y
-0.23
Ch20y
507.9
Ch3m
-2.86
Ch3y
-38.75
Ch5y
3.77
Ch6m
-7.35
Change
0.46%
Change From Open
0.46
Close
4.39
Days Gap
0
Depreciation Amortization
329,736,906
Dollar Volume
231,509,454.8
Earnings Date
2026-04-23
EBIT
CNY 591.7M
EBITDA
CNY 921.5M
EPS
CNY 0.19
F Score
8
FCF
CNY 878.6M
FCF EV Yield
8.3x
FCF Per Share
CNY 0.35
Financing CF
-469,407,040
Fiscal Year End
December
Founded
1,969
Goodwill
184,722,901
Graham Number
3.52669
Graham Upside
-20.03
Income Tax
CNY 167.7M
Investing CF
-450,807,882
Is Primary Listing
1
Last Earnings Date
2026-04-23
Last Report Date
2026-03-31
Last Split Date
2016-06-15
Last Split Type
Forward
Lynch Fair Value
CNY 1.68
Lynch Upside
-61.96
Ma150
4.52
Ma150ch
-2.43%
Ma20
4.52
Ma20ch
-2.46%
Net CF
87,563,073
Next Earnings Date
2026-08-24
Open
4.39
P FCF Ratio
12.73
P OCF Ratio
11.05
Payment Date
2025-06-25
Position In Range
40
Ppne
2,809,246,203
Price Date
2026-05-08
Price EBITDA
CNY 12.14
Ptbv Ratio
1.67
Relative Volume
0.56x
Revenue
6,694,128,210x
Tax By Revenue
2.51x
Tax Rate
25.06%
Tr20y
736.86%
Tr6m
-7.35%
Volume
52,496,475
Z Score
4.12
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHA/600572 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.4%
$0.15 annual per share
Payout ratio
+79.1%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
0.0%
0 consecutive years of growth
Total shareholder yield
+6.7%
Next ex-dividend date: 2025-06-25
Performance

SHA/600572 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+3.2%
S&P 500 1Y: n/a
3Y total return
-32.6%
S&P 500 3Y: n/a
5Y total return
+18.2%
S&P 500 5Y: n/a
10Y total return
-15.8%
S&P 500 10Y: n/a
Ownership

Who owns SHA/600572?

Insider, institutional, and short-interest positioning.

Institutional ownership
+5.3%
Share of float held by funds and institutions
Insider ownership
+2.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-3.3%
Negative means the company is buying back shares.
Technical

SHA/600572 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.6
Neutral momentum band
Price vs 200-day MA
-2.8%
50/200-day relationship not available
Beta (5Y)
0.27
Less volatile than the market
Sharpe ratio
0.09
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/600572

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600572 stock rating?

sha/600572 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600572 analysis?

The full report lives at /stocks/sha/600572/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600572?

The latest report frames sha/600572 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600572 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.